I wonder if Martin Shkreli’s acquisition of Daraprim is going as well as expected?

$750/pill pharma company under investigation by Senate for price gouging • Bipartisan committee to probe Turing and its ilk about pricing practices • 2015 Nov 4 • Beth Mole • Ars Technica